Associate Director | Director - Medical Strategic Accounts

About Us

We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.

With 700+ employees across the UK, Ireland, the Nordics, Germany, the USA, and China, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community. Our core values define who we are:

• People-Driven – We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. And we recognize that the strength in all our collaborations is trust.
• Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
• Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.

We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in oncology supportive care.

Join us in shaping the future of patient care through innovation and collaboration.

This is a field-based position. The ideal candidate should live within easy commuting distance to a major airport in one of the following metro areas:

• Boston
• New York
• Atlanta
• Seattle
• LA
• San Francisco

The Director/Sr. Director, Medical Strategic Account Management is a US medical expert responsible for building and sustaining strategic relationships with national population health decision makers (PHDMs). This position will serve as the field medical lead supporting market access strategy through scientific exchange of the clinical and economic value of PTI therapies/pipeline products to key PHDM stakeholders in community oncology, IDN, payor, GPO, and clinical pathway organizations.

The Director/Sr. Director will compliantly support commercial market access to facilitate access to PTI therapies through proactive engagement of customers, ensuring fair balanced scientific exchange and non-promotional medical information. As a member of the Medical Affairs Leadership Team (MALT), this position will design medical strategies to support appropriate patient selection and PTI product integration into clinical pathways, coordinate medical affairs activities within strategic accounts, and support training and medical excellence initiatives for Medical Affairs stakeholders.

The role of the Director/Sr. Director, Medical Strategic Account Management is non-promotional in nature.

• Execute/Design Medical Affairs strategic account strategies to support market access and facilitate patient access to PTI therapies
• Develop, lead, and maintain relationships with national PHDMs in strategic account segments, including community oncology, IDN, payor, clinical pathway organizations, and GPOs through scientific exchange of the clinical and economic value of PTI approved and pipeline products
• Execute HEOR strategy to PHDMs utilizing economic modeling, value dossiers, real-world evidence, and budget impact models
• Coordinate, direct, and lead national Medical Affairs efforts to ensure the inclusion of PTI therapies in clinical pathways, payor pathways, and treatment order sets
• Collect and analyze insights to adjust medical plans as appropriate
• Identify…